LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 78.98 | 770.25 | 1701 | 11518 | 0.1477 | 0.2251 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.20 | 770.25 | 1668 | 11766 | 0.1418 | 0.2171 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 81.20 | 770.25 | 1733 | 11766 | 0.1473 | 0.2290 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.42 | 770.25 | 1640 | 12031 | 0.1363 | 0.2100 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 83.42 | 770.25 | 1783 | 12031 | 0.1482 | 0.2357 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.64 | 770.25 | 1643 | 12287 | 0.1337 | 0.2088 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 85.64 | 770.25 | 1776 | 12287 | 0.1445 | 0.2325 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 770.25 | 1654 | 12543 | 0.1319 | 0.2091 | MN20160304_L02 | C15 |
| MCF 10A-H2B-mCherry | Dasatinib | 3.1623 | 87.86 | 770.25 | 1818 | 12543 | 0.1449 | 0.2378 | MN20160304_L02 | E18 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.21 | 770.25 | 748 | 904 | 0.8269 | -0.1187 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 3.21 | 770.25 | 792 | 904 | 0.8755 | 0.1275 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 5.44 | 770.25 | 795 | 1012 | 0.7850 | 0.0834 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 5.44 | 770.25 | 826 | 1012 | 0.8156 | 0.1936 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.66 | 770.25 | 838 | 1090 | 0.7688 | 0.1833 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 7.66 | 770.25 | 865 | 1090 | 0.7936 | 0.2606 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.06 | 770.25 | 928 | 1218 | 0.7616 | 0.3252 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 10.06 | 770.25 | 906 | 1218 | 0.7435 | 0.2780 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.28 | 770.25 | 947 | 1358 | 0.6973 | 0.2872 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 12.28 | 770.25 | 959 | 1358 | 0.7061 | 0.3072 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.50 | 770.25 | 994 | 1497 | 0.6639 | 0.3047 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 14.50 | 770.25 | 999 | 1497 | 0.6672 | 0.3115 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.73 | 770.25 | 1007 | 1664 | 0.6050 | 0.2726 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 16.73 | 770.25 | 1017 | 1664 | 0.6110 | 0.2840 | MN20160304_L02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.95 | 770.25 | 1020 | 1832 | 0.5566 | 0.2518 | MN20160304_L02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 18.95 | 770.25 | 1048 | 1832 | 0.5719 | 0.2792 | MN20160304_L02 | N03 |